Moffitt Cancer Center P2C — Tampa, Florida

Moffitt Cancer Center P2C is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Moffitt Cancer Center P2C has participated in 1 clinical trials.

Therapeutic areas: Metastatic Ureter Carcinoma, Metastatic Urethral Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Moffitt Cancer Center P2C?

Moffitt Cancer Center P2C has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Moffitt Cancer Center P2C conducted?

Moffitt Cancer Center P2C has 1 clinical trials on record. Their work covers Metastatic Ureter Carcinoma, Metastatic Urethral Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7.

Is Moffitt Cancer Center P2C accredited by Crixeo Health?

Moffitt Cancer Center P2C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Moffitt Cancer Center P2C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.